Deubiquitylating enzyme, USP9X, regulates proliferation of cells of head and neck cancer lines

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Cell Proliferation

• Publication date

  2016-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/cpr.12273PMID 27374971PMCID PMC6495961
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Deubiquitinase inhibition as a cancer therapeutic strategy.

  2015cited by this paper
• Elevated expression of USP9X correlates with poor prognosis in human non-small cell lung cancer.

  2015cited by this paper
• La FAM fatale: USP9X in development and disease

  2015cited by this paper
• WP1130 increases doxorubicin sensitivity in hepatocellular carcinoma cells through usp9x-dependent p53 degradation.

  2015cited by this paper
• Multifocal epithelial tumors and field cancerization: stroma as a primary determinant.

  2014cited by this paper
• DAPT in the control of human hair follicle stem cell proliferation and differentiation

  2014cited by this paper
• Expression pattern of Notch intracellular domain (NICD) and Hes-1 in preneoplastic and neoplastic human oral squamous epithelium: their correlation with c-Myc, clinicopathological factors and prognosis in Oral cancer

  2014cited by this paper
• Benign reversible encephalopathy syndrome after bevacizumab therapy for metastatic ovarian cancer

  2014cited by this paper
• Ubiquitin-specific peptidase 9, X-linked (USP9X) modulates activity of mammalian target of rapamycin (mTOR).

  2014cited by this paper
• Context-dependent function of the deubiquitinating enzyme USP9X in pancreatic ductal adenocarcinoma

  2014cited by this paper
• Activation of the NOTCH pathway in head and neck cancer.

  2014cited by this paper
• Notch signaling induces EMT in OSCC cell lines in a hypoxic environment

  2013cited by this paper
• Mutational landscape of gingivo-buccal oral squamous cell carcinoma reveals new recurrently-mutated genes and molecular subgroups

  2013cited by this paper
• The pathological significance of Notch1 in oral squamous cell carcinoma

  2013cited by this paper
• USP9X expression correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma

  2013cited by this paper
• Genetic disruption of USP9X sensitizes colorectal cancer cells to 5-fluorouracil

  2012cited by this paper
• The molecular pathogenesis of head and neck squamous cell carcinoma.

  2012cited by this paper
• Ubiquitin-specific Peptidase 9, X-linked (USP9X) Modulates Activity of Mammalian Target of Rapamycin (mTOR)*

  2012cited by this paper
• The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma

  2012cited by this paper
• A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance.

  2012cited by this paper
• Deubiquitinase FAM/USP9X Interacts with the E3 Ubiquitin Ligase SMURF1 Protein and Protects It from Ligase Activity-dependent Self-degradation

  2012cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• The Molecular Pathogenesis of Head and Neck Cancer

  2010cited by this paper
• Deubiquitinase inhibition by small-molecule WP1130 triggers aggresome formation and tumor cell apoptosis.

  2010cited by this paper
• Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival

  2010cited by this paper
• Upregulation of Notch pathway molecules in oral squamous cell carcinoma.

  2010cited by this paper
• Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis.

  2010cited by this paper
• Ribosomal protein S6 kinase 1 interacts with and is ubiquitinated by ubiquitin ligase ROC1.

  2008cited by this paper
• Regulation of ribosomal protein S6 kinases by ubiquitination.

  2008cited by this paper
• Dissecting the Akt/Mammalian Target of Rapamycin Signaling Network: Emerging Results from the Head and Neck Cancer Tissue Array Initiative

  2007cited by this paper
• The Ubiquitin Ligase Itch Is Auto-ubiquitylated in Vivo and in Vitro but Is Protected from Degradation by Interacting with the Deubiquitylating Enzyme FAM/USP9X*

  2006cited by this paper
• Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling.

  2005cited by this paper
• The FAM deubiquitylating enzyme localizes to multiple points of protein trafficking in epithelia, where it associates with E-cadherin and beta-catenin.

  2004cited by this paper
• mTOR Controls Cell Cycle Progression through Its Cell Growth Effectors S6K1 and 4E-BP1/Eukaryotic Translation Initiation Factor 4E

  2004cited by this paper
• Molecular pathogenesis of head and neck squamous cell carcinoma

  2003cited by this paper
• The deubiquitinating enzyme Fam interacts with and stabilizes beta-catenin.

  1999cited by this paper
• Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer.

  1992cited by this paper
• Amplification and overexpression of epidermal growth factor receptor gene in human oropharyngeal cancer.

  1992cited by this paper
• Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line

  1988cited by this paper
• “Field cancerization” in oral stratified squamous epithelium. Clinical implications of multicentric origin

  1953cited by this paper

• Effect of deubiquitinases in head and neck squamous cell carcinoma (Review)

  2025cites this paper
• Deubiquitinases and Cancer

  2024cites this paper
• Nanomaterials exert biological effects by influencing the ubiquitin-proteasome system.

  2024cites this paper
• Ubiquitination-Related Gene Signature, Nomogram and Immune Features for Prognostic Prediction in Patients with Head and Neck Squamous Cell Carcinoma

  2024cites this paper
• Cellular functions, molecular signalings and therapeutic applications: Translational potential of deubiquitylating enzyme USP9X as a drug target in cancer treatment.

  2024cites this paper
• USP14 promotes the cancer stem-like cell properties of OSCC via promoting SOX2 deubiquitination.

  2024cites this paper
• Regulation of post-translational modification of PD-L1 and advances in tumor immunotherapy

  2023cites this paper
• Targeting ubiquitin specific proteases (USPs) in cancer immunotherapy: from basic research to preclinical application

  2023cites this paper
• USP14 Positively Modulates Head and Neck Squamous Carcinoma Tumorigenesis and Potentiates Heat Shock Pathway through HSF1 Stabilization

  2023cites this paper
• The Ubiquitin–Proteasome System in Tumor Metabolism

  2023cites this paper
• The Role of Deubiquitinating Enzyme in Head and Neck Squamous Cell Carcinoma

  2022cites this paper
• Emerging role of ubiquitination/deubiquitination modification of PD-1/PD-L1 in cancer immunotherapy

  2022cites this paper
• Research Progress of Ubiquitin-Specific Pep-tidases in Head and Neck Squamous Cell Carcinoma

  2022cites this paper
• Ubiquitination and Deubiquitination in Oral Disease

  2021cites this paper
• The Impact of the Ubiquitin System in the Pathogenesis of Squamous Cell Carcinomas

  2020cites this paper
• Non-canonical regulation of homologous recombination DNA repair by the USP9X deubiquitylase

  2020cites this paper
• WP1130 reveals USP24 as a novel target in T-cell acute lymphoblastic leukemia

  2019cites this paper
• USP9X stabilizes BRCA1 and confers resistance to DNA‐damaging agents in human cancer cells

  2019cites this paper
• R‐Spondin‐2 Is Upregulated in Idiopathic Pulmonary Fibrosis and Affects Fibroblast Behavior

  2018cites this paper
• Deubiquitination and stabilization of programmed cell death ligand 1 by ubiquitin‐specific peptidase 9, X‐linked in oral squamous cell carcinoma

  2018cites this paper
• Loss of Usp9x disrupts cell adhesion, and components of the Wnt and Notch signaling pathways in neural progenitors

  2017cites this paper